SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MTEN - expected 1000% revenue increase in 97
MTEN 2.820-11.6%3:15 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Hofmann who wrote (236)12/5/1997 10:16:00 PM
From: GR   of 279
 
This steridyne order sounds very promising.PSS is supposedley the largest supplier of hmo's etc for basic stuff.,like low cost thermometers,.etc.,so this will most probably impact in both top and bottom line depending upon how lean and mean they can run the company.Most importantly thesereg s shares seem to have been retired so they are no longer dilutive.As nearly everyone who was originally on this thread seems to have vanished.,it would be interesting to see if anyone really understands the new debt/equity refinancing., and can comment.Does this imply that there are no more any reg s shares?-as i understand? If in fact the loss was caused in large part by one time acquistive and amalgamating charges the return to profitability may be sonner than we think.The share price may also sonn reflect this increased optimisim-especially if some positive news distribution about this company emerges.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext